Sputum Gene Expression Reveals Dysregulation of Mast Cells and Basophils in Eosinophilic COPD
Natasha A Winter,Peter G Gibson,Vanessa M McDonald,Michael Fricker
DOI: https://doi.org/10.2147/COPD.S305380
2021-07-21
International Journal of COPD
Abstract:Natasha A Winter, 1– 3 Peter G Gibson, 1– 5 Vanessa M McDonald, 1, 2, 4, 6 Michael Fricker 1– 4 1 National Health and Medical Research Council Centre for Research Excellence in Severe Asthma, Newcastle, NSW, Australia; 2 The Priority Research Centre for Health Lungs, The University of Newcastle, Newcastle, NSW, Australia; 3 School of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, Australia; 4 Hunter Medical Research Institute, Newcastle, NSW, Australia; 5 Department of Respiratory and Sleep Medicine, John Hunter Hospital, Hunter Medical Research Institute, Newcastle, NSW, Australia; 6 School of Nursing and Midwifery, The University of Newcastle, Newcastle, NSW, Australia Correspondence: Michael Fricker The Priority Research Centre for Healthy Lungs, The University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW, 2305, Australia Tel +64 2 4042 0207 Email Purpose: The clinical and inflammatory associations of mast cells (MCs) and basophils in chronic obstructive pulmonary disease (COPD) are poorly understood. We previously developed and validated a qPCR-based MC/basophil gene signature in asthma to measure these cells in sputum samples. Here, we measured this gene signature in a COPD and control population to explore the relationship of sputum MCs/basophils to inflammatory and COPD clinical characteristics. Patients and Methods: MC/basophil signature genes ( TPSAB1/TPSB2, CPA3, ENO2, GATA2, KIT, GPR56, HDC, SOCS2) were measured by qPCR in sputum from a COPD (n=96) and a non-respiratory control (n=17) population. Comparative analyses of gene expression between the COPD and the control population, and between eosinophilic COPD and non-eosinophilic COPD were tested. Logistic regression analysis and Spearman correlation were used to determine relationships of sputum MC/basophil genes to inflammatory (sputum eosinophil proportions, blood eosinophils) and clinical (age, body mass index, quality of life, lung function, past year exacerbations) characteristics of COPD. Results: MC/basophil genes were increased in COPD versus control participants ( CPA3, KIT, GATA2, HDC) and between eosinophilic-COPD and non-eosinophilic COPD ( TPSB2, CPA3, HDC, SOCS2 ). We found all MC/basophil genes were positively intercorrelated. In COPD, MC/basophil genes were associated with eosinophilic airway inflammation ( GATA2, TPSB2, CPA3, GPR56, HDC, SOCS2 ), blood eosinophilia (all genes) and decreased lung function ( KIT, GATA2, GPR56, HDC ). Conclusion: We demonstrate associations of MCs and basophils with eosinophilic inflammation and lower lung function in COPD. These findings are consistent with prior results in asthma and may represent a new tool for endotyping eosinophilic-COPD. Keywords: basophils, mast cells, COPD, gene expression, inflammation Mast cells (MCs) and basophils are important granulocytes that exert numerous immune functions, the dysregulation of which promote airway inflammation, bronchoconstriction and airway remodelling. The scarcity of these immune cells in the airways and the absence of MCs from circulation make them challenging to study in the clinical context and their inflammatory and clinical associations in COPD remain poorly understood. We have previously developed and validated a qPCR-based MC/basophil gene signature in asthma that reflects the abundance of these cells in sputum samples. Here, we apply this gene signature in a COPD cohort (n=96) and non-respiratory disease controls (n=17), demonstrating dysregulation of sputum MCs and basophils in COPD. Sputum MC/basophil-related gene expression was related to airway and systemic eosinophilic inflammation and lower lung function in COPD. These novel findings demonstrate potentially automatable PCR-based measure of airway MCs/basophils in COPD and reveal dysregulation of lumen MCs and basophils and associations with important clinical and inflammatory characteristics in COPD. COPD is the third leading cause of death and fifth cause of disability worldwide. 1 Disease progression is marked by lung function decline and increased exacerbations of worsening symptoms. 2 Inflammation plays an integral pathophysiological role in COPD. Patients can present with varied inflammatory patterns, the most well described being neutrophilic airway inflammation. 3 However, eosinophilic inflammation, in sputum and blood, is also present in a significant number of individuals with COPD. 4–8 Eosinophili -Abstract Truncated-